OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Wake Forest University

4 Projects | 3 Researchers | $3,599,379 Invested

2022

Wake Forest University

Miranda Orr, PhD

2022 Annual Goodes Prize for Excellence in Alzheimer's Drug Discovery: Senescence Biomarker Discovery

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Tau
  • Status: Active

2020

Wake Forest University

Miranda Orr, PhD

Phase II Clinical Trial to Evaluate the Safety and Feasibily of Senolytic Therapy in Alzheimer's Disease

  • Funding Amount: $3,439,379
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Tau
  • Status: Active

2007

Wake Forest University

Sally Shumaker, PhD

11th Biennial Graylyn Conference on Women's Cognitive Health

  • Funding Amount: $2,500
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed

2002

Wake Forest University

James Toole, PhD

Planning for A Prospective, Randomized Study for the Prevention & Treatment of Post-Stroke Dementia

  • Funding Amount: $7,500
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed